Adverse drug events in cognitively impaired elderly patients

Dementia and Geriatric Cognitive Disorders

Volumn 23, Issue 6, 2007, Pages 395-400

  Ganjavi, Hooman ^a,e   Herrmann, Nathan ^a,d,e   Rochon, Paula A ^b,d   Sharma, Papita ^a,e   Lee, Monica ^b,c   Cassel, Daniel ^a   Freedman, Morris ^b,e   Black, Sandra E ^a,e   Lanctôt, Krista L ^a,b,d,e  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b Kunin Lunenfeld Applied Research Unit and Department of Food and Nutrition Services and Baycrest Centre for Geriatric Care   (Canada)

^c BAYCREST CENTRE FOR GERIATRIC CARE   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

Adverse drug events; Cognitive impairment; Elderly population; Natural health products

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CENTRAL NERVOUS SYSTEM AGENTS; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE INHIBITOR; GASTROINTESTINAL AGENT; HERBACEOUS AGENT; LITHIUM; MINERAL; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VITAMIN;

ADVERSE OUTCOME; AGED; ARTICLE; BLEEDING; BRADYCARDIA; CLINICAL EVALUATION; COGNITIVE DEFECT; CONFIDENCE INTERVAL; CONTROLLED STUDY; DELUSION; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DIZZINESS; FATIGUE; FEMALE; GAIT DISORDER; GERIATRIC HOSPITAL; HEADACHE; HUMAN; HYPERGLYCEMIA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RASH; RIGIDITY; RISK ASSESSMENT; SEDATION; STATISTICAL ANALYSIS; STOMACH DISEASE; SYNCOPE; TREMOR; UNSPECIFIED SIDE EFFECT; XEROSTOMIA;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGE FACTORS; AGED; AGED, 80 AND OVER; COGNITION DISORDERS; COMPLEMENTARY THERAPIES; DRUG INTERACTIONS; DRUG THERAPY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; ONTARIO; PHARMACEUTICAL PREPARATIONS; RISK FACTORS; SELF ADMINISTRATION; SELF MEDICATION; SEVERITY OF ILLNESS INDEX;

EID: 34250208803     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101454     Document Type: Article

References (51)

1. Routledge PA, O'Mahony MS, Woodhouse KW: Adverse drug reactions in elderly patients. Br J Clin Pharmacol 2004; 57:121-126.
2. Gholami K, Shalviri G: Factors associated with preventability, predictability, and severity of adverse drug reactions. Ann Pharmacother 1999;33:236-240.
3. Bordet R, Gautier S, Le Louet H, Dupuis B, Caron J: Analysis of the direct cost of adverse drug reactions in hospitalised patients. Eur J Clin Pharmacol 2001;56:935-941.
4. Dormann H, Krebs S, Muth-Selbach U, Criegee-Rieck M, Radespiel-Troger M, Levy M, Hahn EG, Brune K, Schneider HT: Adverse drug reactions in patients with gastroenterological diseases: does age increase the risk? Aliment Pharmacol Ther 2001;15:171-180.
5. Carbonin P, Pahor M, Bernabei R, Sgadari A: Is age an independent risk factor of adverse drug reactions in hospitalized medical patients? J Am Geriatr Soc 1991;39:1093-1099.
6. Gurwitz JH, Avorn J: The ambiguous relation between aging and adverse drug reactions. Ann Intern Med 1991;114:956-966.
7. Cooper JW: Probable adverse drug reactions in a rural geriatric nursing home population: a four-year study. J Am Geriatr Soc 1996;44:194-197.
8. Williamson J, Chopin JM: Adverse reactions to prescribed drugs in the elderly: a multicentre investigation. Age Ageing 1980;9:73-80.
9. Davidsen F, Haghfelt T, Gram LF, Brosen K: Adverse drug reactions and drug non-compliance as primary causes of admission to a cardiology department. Eur J Clin Pharmacol 1988;34:83-86.
10. Rawlins M, Thompson JP: Pathogenesis of Adverse Drug Reactions: Textbook of Adverse Drug Reactions. Oxford, Oxford University Press, 1977, vol 44.
11. Moore N, Lecointre D, Noblet C, Mabille M: Frequency and cost of serious adverse drug reactions in a department of general medicine. Br J Clin Pharmacol 1998;45:301-308.
12. Green CF, Mottram DR, Rowe PH, Pirmohamed M: Adverse drug reactions as a cause of admission to an acute medical assessment unit: a pilot study. J Clin Pharm Ther 2000;25:355-361.
13. McDonnell PJ, Jacobs MR: Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 2002;36:1331-1336.
14. Beijer HJ, de Blaey CJ: Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 2002;24:46-54.
15. Onder G, Gambassi G, Scales CJ, Cesari M, Vedova CD, Landi F, Bernabei R: Adverse drug reactions and cognitive function among hospitalized older adults. Eur J Clin Pharmacol 2002;58:371-377.
16. Ruscin JM, Semla TP: Assessment of medication management skills in older outpatients. Ann Pharmacother 1996;30:1083-1088.
17. Sunderland T, Tariot PN, Newhouse PA: Differential responsivity of mood, behavior, and cognition to cholinergic agents in elderly neuropsychiatric populations. Brain Res 1988;472:371-389.
18. Schmader KE, Hanlon JT, Fillenbaum GG, Huber M, Pieper C, Horner R: Medication use patterns among demented, cognitively impaired and cognitively intact community-dwelling elderly people. Age Ageing 1998;27:493-501.
19. Landi F, Gambassi G, Lapane KL, Sgadari A, Gifford D, Mor V, Bernabei R: Comorbidity and drug use in cognitively impaired elderly living in long-term care. Dement Geriatr Cogn Disord 1998;9:347-356.
20. Gold JL, Laxer DA, Dergal JM, Lanctôt KL, Rochon PA: Herbal-drug therapy interactions: a focus on dementia. Curr Opin Clin Nutr Metab Care 2001;4:29-34.
21. Brazier NC, Levine MA: Drug-herb interaction among commonly used conventional medicines: a compendium for health care professionals. Am J Ther 2003;10:163-169.
22. Dergal JM, Gold JL, Laxer DA, Lee MS, Binns MA, Lanctot KL, Freedman M, Rochon PA: Potential interactions between herbal medicines and conventional drug therapies used by older adults attending a memory clinic. Drugs Aging 2002;19:879-886.
23. Fugh-Berman A, Cott JM: Dietary supplements and natural products as psychotherapeutic agents. Psychosom Med 1999;61:712-728.
24. Coleman LM, Fowler LL, Williams ME: Use of unproven therapies by people with Alzheimer's disease. J Am Geriatr Soc 1995;43:747-750.
25. Hogan DB, Ebly EM: Complementary medicine use in a dementia clinic population. Alz heimer Dis Assoc Disord 1996;10:63-67.
26. Sharma P, Herrmann N, Rochon PA, Lee M, Croxford R, Rothenburg L, Black SE, Lanctôt KL: Perceptions of natural health products among patients attending a memory clinic. Am J Alzheimers Dis Other Demen 2006;21:156-163.
27. Folstein MF, Folstein SE, McHugh PR: Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
28. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383.
29. Bates DW, Leape LL, Cullen DJ, Laird N, Petersen LA, Teich JM, Burdick E, Hickey M, Kleefield S, Shea B, Vander Vliet M, Seger DL: Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 1998;280:1311-1316.
30. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, Laffel G, Sweitzer BJ, Shea BF, Hallisey R, et al: Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 1995;274:29-34.
31. Gurwitz JH, Field TS, Avorn J, McCormick D, Jain S, Eckler M, Benser M, Edmondson AC, Bates DW: Incidence and preventability of adverse drug events in nursing homes. Am J Med 2000;109:87-94.
32. Onder G, Pedone C, Landi F, Cesari M, Della Vedova C, Bernabei R, Gambassi G: Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 2002;50:1962-1968.
33. Onder G, Landi F, Della Vedova C, Atkinson H, Pedone C, Cesari M, Bernabei R, Gambassi G: Moderate alcohol consumption and adverse drug reactions among older adults. Pharmacoepidemiol Drug Saf 2002;11:385-392.
34. Hajjar ER, Hanlon JT, Artz MB, Lindblad CI, Pieper CF, Sloane RJ, Ruby CM, Schmader KE: Adverse drug reaction risk factors in older outpatients. Am J Geriatr Pharmacother 2003;1:82-89.
35. Lazarou J, Pomeranz BH, Corey PN: Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998;279:1200-1205.
36. Hanlon JT, Pieper CF, Hajjar ER, Sloane RJ, Lindblad CI, Ruby CM, Schmader KE: Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay. J Gerontol A Biol Sci Med Sci 2006;61:511-515.
37. Gray SL, Mahoney JE, Blough DK: Adverse drug events in elderly patients receiving home health services following hospital discharge. Ann Pharmacother 1999;33:1147-1153.
38. Feinberg M: The problems of anticholinergic adverse effects in older patients. Drugs Aging 1993;3:335-348.
39. Kirking DM, Lerman RH, Ascione FJ, Jarawan ST, Fries BE: Adverse drug reactions in an older, predominantly male, ambulatory population. J Geriatr Drug Ther 1996;10:39-50.
40. Hanlon JT, Schmader KE, Koronkowski MJ, Weinberger M, Landsman PB, Samsa GP, Lewis IK: Adverse drug events in high risk older outpatients. J Am Geriatr Soc 1997;45:945-948.
41. Gray SL, Sager M, Lestico MR, Jalaluddin M: Adverse drug events in hospitalized elderly. J Gerontol A Biol Sci Med Sci 1998;53:M59-M63.
42. Bates DW: Drugs and adverse drug reactions: how worried should we be? JAMA 1998;279:1216-1217.
43. McCormick WC, Kukull WA, van Belle G, Bowen JD, Teri L, Larson EB: Symptom patterns and comorbidity in the early stages of Alzheimer's disease. J Am Geriatr Soc 1994;42:517-521.
44. Callahan CM, Hendrie HC, Tierney WM: Documentation and evaluation of cognitive impairment in elderly primary care patients. Ann Intern Med 1995;122:422-429.
45. Lanctôt K, Bowles SK, Herrmann N, Best TS, Naranjo CA: Drugs mimicking dementia - dementia symptoms associated with psychotropic drugs in institutionalised cognitively impaired patients. CNS Drugs 2000;14:381-390.
46. Berlinger WG, Spector R: Adverse drug reactions in the elderly. Geriatrics 1984;39:45-57.
47. Gurvich T, Cunningham JA: Appropriate use of psychotropic drugs in nursing homes. Am Fam Physician 2000;61:1437-1446.
48. Glass J, Lanctôt KL, Herrmann N, Sproule BA, Busto UE: Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 2005;331:1169.
49. Gray SL, Lai KV, Larson EB: Drug-induced cognition disorders in the elderly: incidence, prevention and management. Drug Saf 1999;21:101-122.
50. Monette J, Gurwitz JH, Avorn J: Epidemiology of adverse drug events in the nursing home setting. Drugs Aging 1995;7:203-211.
51. Simpson GM, Pi EH, Sramek JJ Jr: Adverse effects of antipsychotic agents. Drugs 1981;21:138-151.